Crossmark

Clinical effectiveness of three months once-weekly Isoniazid and Rifapentine regimen for treatment of Latent TB Infection: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12879-026-13607-w

Published Online: 2026-06-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Muniyandi, Malaisamy

Kothoju, Bhaskara Chary

Chelvanayagam, Karthick

Balachandran, Balagopal

Palani, Bharathidasan

Janagaraj, Venkateshprabhu

Thirupathi, Vijaykaravell

Nagarajan, Karikalan
License Information

Text and Data Mining valid from 2026-06-04

Version of Record valid from 2026-08-10
More Information

Article History

Received: 30 January 2026

Accepted: 12 May 2026

First Online: 4 June 2026

Declarations

Ethics approval and consent to participate: Not applicable.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below